BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 947865)

  • 41. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
    Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
    J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
    Pompecki R; Shively JE; Todd CW
    Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum immunoglobulins in genitourinary malignancies.
    Schmidt JD; Feldbush TL; Weinstein SH; Bonney WW
    J Urol; 1976 Mar; 115(3):293-5. PubMed ID: 943578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological evaluation in patients with urological cancers.
    Martinez-Piñeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The carcinoembryonic antigen test in urologic cancer.
    Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
    Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
    World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin testing in genitourinary carcinoma: 2-year followup.
    Decenzo JM; Allison R; Leadbetter GW
    J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [CEA-determinations in the serum of patients with carcinoma of the large intestine].
    Lamerz R; Ruider H
    Z Gastroenterol Verh; 1976; (11):79-84. PubMed ID: 65869
    [No Abstract]   [Full Text] [Related]  

  • 54. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 55. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical applications of the radioimmunoassay of carcinoembryonic antigen].
    Saccani F; Saccani Jotti G; Bagni B
    Acta Biomed Ateneo Parmense; 1982; 53(5):361-7. PubMed ID: 6220548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Value of alpha-2 globulin, as a biological tracer in the urothelial carcinoma].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Arch Esp Urol; 1978; 31(3):225-34. PubMed ID: 80976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate and transitional cell carcinoma: radioimmunoassay of viral tumor-associated antigens.
    Mickey DD; Paulson DF
    Natl Cancer Inst Monogr; 1978 Dec; (49):51-3. PubMed ID: 86167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.